ArticleBMC psychiatry2025
Screening for symptoms of depression, anxiety and associated factors among leprosy patients at referral hospitals in the Amhara region, Ethiopia.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeprosy, a neglected tropical disease (NTD), is closely associated with stigma and discrimination, particularly in low- and middle-income countries, which significantly worsen mental health challenges. In Ethiopia's Amhara region, leprosy accounts for 26.1% of cases, often leading to stigma, isolation, and increased depression and anxiety risk. This study aimed to assess depression and anxiety symptoms among leprosy patients in hospitals across the Amhara region, providing a basis for targeted mental health interventions and policies. METHODS AND MATERIALS: An institution-based cross-sectional study was conducted in three referral hospitals in the Amhara region from December 14 to 20, 2023. The Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder-7 (GAD-7) assessment tools were used to evaluate symptoms of depression and anxiety, respectively. Binary logistic regression was employed to identify factors associated with symptoms of depression and anxiety, using a significance level of p ≤ 0.05.
resultsAmong 383 participants, 36% reported depressive symptoms, and 32.6% experienced anxiety symptoms. Several factors were found to significantly contribute to mental health symptoms in individuals with leprosy. Symptoms of depression were significantly associated with being female (AOR = 1.20; 95% CI: 1.09-3.42), being aged above 50 years (AOR = 2.42; 95% CI: 1.23-3.22), having a chronic disease (AOR = 1.64; 95% CI: 1.07-3.66), having multibacillary leprosy (AOR = 1.40; 95% CI: 1.08-3.22), and being on multidrug therapy (AOR = 1.20; 95% CI: 1.12-3.22). Similarly, symptoms of anxiety were more likely among individuals who were female (AOR = 1.34; 95% CI: 1.14-2.67), had chronic diseases (AOR = 1.40; 95% CI: 1.05-2.70), smoked (AOR = 1.25; 95% CI: 1.02-2.40), had multibacillary leprosy (AOR = 1.40; 95% CI: 1.10-3.30), or had borderline lepromatous leprosy (AOR = 1.30; 95% CI: 1.05-2.10). CONCLUSION AND RECOMMENDATIONS: This study identified factors influencing anxiety and depression in leprosy patients, including gender, age, disease classification, multidrug therapy, chronic diseases, and smoking habits. It is important to note that the study assesses symptoms, not diagnoses. The Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) questionnaires are crucial for early detection, especially in high-risk groups such as females, older adults, and those with chronic or multibacillary leprosy. Routine screening and integrating mental health assessments into care, along with specialized services and awareness campaigns, will improve patient outcomes and reduce the psychosocial impact of leprosy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.